Heparin treatment reduces glomerular injury in rats with adriamycin-induced Nephropathy but does not modify tubulointerstitial damage or the renal production of transforming growth factor-beta

Nephron

Volumn 84, Issue 3, 2000, Pages 248-257

  Baroni, Edmara A ^b   Costa, Roberto S ^b   Da Silva, Cleonice G A ^b   Coimbra, Terezila Machado ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE

Author keywords

Adriamycin nephropathy; Glomerulosclerosis; Heparin; Proteinuria; Renal fibrosis; Transforming growth factor

Indexed keywords

ALBUMIN; CREATININE; DOXORUBICIN; HEPARIN; MESSENGER RNA; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULOPATHY; GLOMERULOSCLEROSIS; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INTERSTITIAL NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN URINE LEVEL; RAT; RNA ANALYSIS;

EID: 0034014353     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045585     Document Type: Article

References (50)

1. Bertani T, Poggi A, Pozzoni R, DeLaini F, Sacchi G, Thoua Y, Mecca G, Remuzzi G, Donati MB: Adriamycin-induced nephrotic syndrome in rats. Lab Invest 1982;46:16-23.
2. Bertani T, Cutillo F, Zoja C, Brogginne M, Remuzzi G: Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy. Kidney Int 1986;30:488-496.
3. Bertani T, Rocchi G, Sacchi G, Mecca G, Remuzzi G: Adriamycin-induced glomerulosclerosis in the rat. Am J Kidney Dis 1986;7: 12-19.
4. Okuda S, Oh Y, Tsuruda H, Onoyama E, Fujimi S, Fujishima M: Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease. Kidney Int 1986;29:502-510.
5. Skutelsky E, Hartzan S, Socher R, Gafter U: Modifications in glomerular polyanion distribution in adriamycin nephrosis. J Am Soc Nephrol 1995;5:1799-1805.
6. 1. Nature 1990;346: 371-374.
7. Coimbra TM, Wiggins RC, Noh JW, Merritt S, Phan SH: Transforming growth factor-β production in anti-glomerular basement disease in the rabbit. Am J Pathol 1991;138:223-234.
8. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E: Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney. J Clin Invest 1993;92: 2597-2601.
9. Sharma K, Ziyadeh FN: The emerging role of transforming growth factor-β in kidney diseases. Am J Physiol 1994;266:F829-F842.
10. 1 in the development of rat diabetic ncphropathy. A 10-month study with insulin-treated rats. Nephron 1996;74:189-196.
11. Monteiro de Freitas AS, Coimbra TM, Costa RS, Baroni EA: Urinary transforming growth factor-β excretion and renal production of TGF-β in rats with subtotal renal ablation: effect of enalapril and nifedipine. Nephron 1998;78:302-309.
12. Tamaki K, Okuda S, Miyazono K, Nakayama M, Fujishima M: Matrix-associated latent TGF-β with latent TGF-β binding protein in the progressive processes in adriamycin-induced nephropathy. Lab Invest 1995;73:81-89.
13. 1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy. Kidney Int 1994;45: 525-536.
14. Pieroni F, Costa RS, Coimbra TM: Effects of glycosaminoglycans on the glomerular changes induced by adriamycin. Res Exp Med 1995; 195:373-379.
15. Nader HB, Buonassisi V, Colburn P, Dietrich CP: Heparin stimulates the synthesis and modifies the sulfation pattern of heparan sulfate proteoglycan from endothelial cells. J Cell Physiol 1989;140:305-310.
16. Gambaro G, Venturini AP, Noonan DM, Fries W, Re G, Garbisa S, Milanesi C, Pesarini A, Borsatti A, Marchi E, Baggio B: Treatment with glycosaminoglycan formulation ameliorates experimental diabetic nephropathy. Kidney Int 1994;46:797-806.
17. Gambaro G, Cavazzana AO, Luzi P, Piccoli A, Borsatti A, Crepaldi G, Marchi E, Venturini AP, Baggio B: Glycosaminoglycans prevent morphological renal alterations and albuminuria in diahetic rats. Kidney Int 1992;42:285-291.
18. Eddy AA, McCulloch L, Liu E, Adams J: A relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephrotic syndrome. Am J Pathol 1991;138: 1111-1123.
19. Eddy AA, Giachelli CM: Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 1995;47:1546-1557.
20. Remuzzi G, Ruggenenti P, Benigni A: Understanding the nature of renal disease progression. Kidney Int 1997;51:2-15.
21. Zoja C, Donadelli R, Colleoni S, Figliuzzi M, Bonazzola S, Morigi M, Remuzzi G: Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kB activation. Kidney Int 1998;53:1608-1615.
22. Floege J, Eng E, Young BA, Couser WG, Johnson RJ: Heparin supresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int 1993;43:369-380.
23. Burg M, Ostendorf T, Mooney A, Koch K-M, Floege J: Treatment of experimental mesangio-proliferative glomerulonephritis with non-anti-coagulant heparin: Therapeutic efficacy and safety. Lab Invest 1997;76:505-516.
24. Striker LJ. Peten EP. Elliot SJ, Doi T, Striker GE: Mesangial cell turnover: Effect of heparin and peptide growth factors. Lab Invest 1991; 64:446-456.
25. Benador NM, Girardin EP: Influence of heparin and type-IV collagen on IL-6 synthesis by rat glomerular mesangial cells. Nephron 1997; 77:219-224.
26. Laurell CB: Electroimmunoassay. Scand J Clin Lab Invest 1972;124(suppl):21-23.
27. 1: Histochemical localization with antibodies to different epitopes. J Cell Biol 1989;108:653-660.
28. Kliem V, Johnson RJ, Alpers CE, Yoshimura A, Couser WG, Koch KM, Floege J: Mechanisms involved inthepathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int 1996;49:666-678.
29. Russ JC: The Image Processing Handbook. Ann Arbor, CRC Press, 1995.
30. Chomezynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
31. Maniatis T, Fritsh EF, Sambrook J: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, Cold Spring Harbor Laboratory Press, 1989.
32. Derynek RJ, Jarrett JA, Chen EY. Eaton DH, Bell JR, Assoian RK, Roberts AB, Sporn MB, Goeddel DV: Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 1985;316:701-705.
33. Chan YL, Olivers J, Wood IG: The structure of rat 28 S rihosomal acid inferred from the sequence of nucleotides in a gene. Nucleic Acids Res 1983;11:7819-7831.
34. Feinberg AP, Vogelstein B: A technique for labelling DNA restriction endonuclease fragments to high specific activity. Anal Bioehem 1983;132:6-13.
35. Danielpour D, Kim KY, Dart LL, Watanabe S, Roberts AB, Sporn MB: Sandwich enzyme-linked immunosorbent assays quantitate and distinguish two forms of transforming growth factor-beta in complex biological fluids. Growth Factors 1989;2:61-65.
36. Haygen HN: The determination of 'endogenous creatinine' in plasma and urine. Scand J Clin Lab Invest 1953;5:48-57.
37. Kriz W, Elger M, Nagata M, Kretzler M, Uiker S, Koeppen-Hageman I, Tenschert S, Lemley KV: The role of podocytes in the development of glomerular sclerosis. Kidney Int 1994; 45(suppl):64-72.
38. Floege J, Johnson RJ, Alpers CE, Fatemi-Nainie S, Richardson CA, Gordon K, Couser WG: Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor-β-chain. Am J Pathol 1993;142: 637-650.
39. Coffey AK, Karnovsky MJ: Heparin inhibits mesangial cell proliferation in Habuvenom-induced glomerular injury. Am J Pathol 1985; 120:248-255.
40. Purkerson ML, Tollefsen DM, Klahr S: N-Desulfated/acetylated heparin ameliorates the progression of renal disease in rats with subtotal renal ablation. J Clin Invest 1988;81:69-74.
41. Adler S: Inhibition of rat glomerular visceral epithelial cell growth by heparin. Am J Physiol 1988;255:F781-F786.
42. Ballerman BJ: Regulation of bovine glomerular endothelial cell growth in vitro. Am J Physiol 1989;256:C182-C189.
43. Wardle EN: Heparins for proliferative nephritides? Short review on an advancing topic. Nephron 1996;73:515-519.
44. Remuzzi G, Bertuni T: Editorial review: Is glomerulosclerosis a consequence of altered permeability to macromolecules. Kidney Int 1990; 38:384-394.
45. Kagami S, Border WA, Miller DE, Noble NA: Angiotensin stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular cells. J Clin Invest 1994;93:2431-2437.
46. Zoja C, Morigi M, Figliuzzi M, Bruzzi I, Oldroyd S, Benigini A, Ronco PM, Remuzzi G: Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins. Am J Kidney Dis 1995;26:934-941.
47. Kohan DE: Angiotensin and endothelin in chronic glomerulonephritis. Kidney Int 1998; 54:646-647.
48. Grainger DJ, Mosedale DE, Metcalfe JC, Weissberg PL, Kemp PR: Active and acid-activatable TGF-β in sera, platelets and plasma. Clin Chim Acta 1995;235:11-31.
49. Noh JW, Wiggins RC, Phan SH: Urine transforming growth factor-β activity is related to the degree of scarring in crescentic nephritis in rabbit. Nephron 1993;63:73-78.
50. Dominguez GCS, Costa RS, Dantas M, Kimachi T, Piuci CR, Coimbra TM: Transforming growth factor β activity in urine from patients with glomerulonephritis is related to their renal functional and structural changes. Nephrology 1998;4:31-35.